WHO’s First ‘Investment Round’: Addressing Ethical Dilemmas in Global Health Funding
GS4GS2
The World Health Organization (WHO) has initiated its first-ever Investment Round to secure $7 billion in flexible funding for its 2025-2028 strategy. This move aims to reduce dependence on earmarked contributions, ensuring the organization can prioritize global health needs impartially and ethically.
The World Health Organization (WHO) has officially launched its inaugural 'Investment Round,' a strategic shift in its financing model designed to secure $7 billion in flexible, predictable funding for the period 2025–2028. This initiative, introduced during the 77th World Health Assembly, represents a critical attempt to reform the organization’s financial architecture and address long-standing ethical concerns regarding international health governance.
For decades, the WHO has faced a structural funding crisis. While its mandate is to serve as the global authority on health, nearly 80% of its budget has historically come from voluntary contributions. Most of these funds are 'earmarked,' meaning donors—ranging from wealthy nations to private foundations—specify exactly which programs or diseases the money must be used for. This creates a 'principal-agent' dilemma where the WHO’s priorities are often dictated by donor interests rather than the most pressing global health needs or the requirements of the Global South.
Continue reading — free with login
JeetoBharat publishes daily UPSC current affairs mapped to the Mains syllabus. Log in to read full articles.
Log in to read full articleNo credit card required. Free registered users get unlimited access.
This article was curated using AI. While we strive for accuracy, please verify critical facts from official sources.